Health Tech: A tiny gadget takes on a giant health problem

Health Tech: A tiny gadget takes on a giant health problem

Jun 15, 2017 · 23 min

People

  • Todd Bishop
  • Claire McGrain Host
  • Jeff LaBrune Guest
  • Chuks O. Guest
  • Auto Saip Guest

Listen on

Suggest an edit

Taking a pill isn’t so hard. The tricky thing is remembering to take it. Patients not taking medication properly is a huge problem for the health industry, but these three entrepreneurs think they have a solution: A gadget that can fit in the palm of your hand. Thank you to our sponsor, Providence St. Joseph Health’s Digital and Innovation Group. Follow them at twitter.com/provinnovation. See omnystudio.com/listener for privacy information.

Seattle Tacoma International Airport Pilzy UNITED STATES University of Michigan The Wall Street Journal

Chapters

  1. 0:00 Introduction to the problem of medication adherence
  2. 0:36 Introducing Jeff LaBrune and the genesis of Pilzy
  3. 1:00 The concept of a smart, connected pill bottle
  4. 1:17 Sponsor message: Providence St. Joseph Health
  5. 1:37 Introducing the Pilzy co-founders: Jeff, Chuks, and Auto
  6. 2:31 Personal stories behind the idea
  7. 3:37 Research on medication adherence and existing devices
  8. 4:00 The development and design of Pilzy
  9. 5:32 The complexity of Pilzy's software and caregiver features
  10. 6:30 Pilzy's reminder system and prevention of double dosing
  11. 7:37 Potential uses of Pilzy data and target markets
  12. 8:06 Challenges faced by health tech startups
  13. 8:18 Sponsor message: Providence St. Joseph Health
  14. 8:44 The size and nature of the healthcare industry
  15. 9:12 Startup challenges in the healthcare industry
  16. 9:41 Pilzy's funding and investment strategy
  17. 10:01 Navigating conservative industries and customer acquisition
  18. 10:31 Healthcare as an opportunity for tech startups
  19. 10:51 The unique economics of the healthcare industry
  20. 11:07 The impact of health insurance policy and uncertainty
  21. 11:40 Pilzy featured in the Wall Street Journal

Conversation

No comments yet.